Skip to Main Content

Paper Details

High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma.
Pharmaceuticals (Basel)
0
2022
Author NameAffiliation
Sirano Dhe-PaganonDana-Farber Cancer Institute
Sirano Dhe-PaganonHarvard Medical School
Richard MorigglInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna
  • 1 - 3

Datasets

Release 1.2